United States · Series B startup

Who invested in LogicBio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$45Mraised across 1 round since 2017, from 1 source

Latest round
Series B, $45MJun 2017
Investors
5
See who backed them

The rounds

  1. Jun 2017
    Series B$45M

    Also list them on their own siteAndera Partners

    Reported by FinSMEs

Everyone who backed them

OrbiMedPrivate equity1round
SBIGrowth equity1round
Arix Bioscience/ OrbiMedGrowth equity1round
Edmond De Rothschildno record of our own yet1round
Pontifaxno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list LogicBio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Andera PartnersPrivate equity2017, per its site
Horizon Technology FinanceVenture debtPer its own site

Quick answers about LogicBio

Who invested in LogicBio?

LogicBio's investors include OrbiMed, SBI, Arix Bioscience/ OrbiMed, Edmond De Rothschild and Pontifax.

How much has LogicBio raised?

LogicBio has raised $45M across 1 round since 2017.

When did LogicBio last raise?

LogicBio's most recent round was a Series B of $45M in Jun 2017.

What was LogicBio's biggest round?

Its most recent round, $45M in Jun 2017, is also its largest on record.

Who backed LogicBio first?

LogicBio's first round on record, in Jun 2017, was backed by OrbiMed, SBI and Arix Bioscience/ OrbiMed and 2 others.

What stage is LogicBio at?

LogicBio's latest named round is a Series B, in Jun 2017.

Where is LogicBio based?

LogicBio is based in the United States.

Companies like LogicBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.